Deep Track Capital, LP 13D/13G Filings for Avalo Therapeutics, Inc. (AVTX)

Deep Track Capital, LP 13D and 13G filings for Avalo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-04-05
4:00 pm
Purchase
2024-03-27 13G Avalo Therapeutics, Inc.
AVTX
Deep Track Capital, LP 114,775
9.990%
114,775increase
(New Position)
Filing